Dermalo Bath Emollient
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Dermalo Bath Emollient
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Liquid Paraffin 65.0% w/w
Acetylated Wool Alcohols 5.0% w/w
3. PHARMACEUTICAL FORM
BATH ADDITIVE
Dye- and fragrance-free colourless to straw coloured clear oily liquid.
4. CLINICAL PARTICULARS
4.1. Therapeutic Indications
For the symptomatic relief of contact dermatitis, atopic dermatitis, senile pruritus, ichthyosis and related dry skin disorders.
4.2. Posology and Method of Administration
Adults, including the elderly:
Add 15 to 20 ml (1/ to 2 capfuls) to a standard bath of water (8 inch depth). Immerse and cover the affected areas with the bath water and soak for 10 to 20 minutes. Pat dry with a towel. Alternatively, use a similar amount smoothed onto wet skin following a shower. Rinse off thoroughly and pat dry with a towel.
Infants and children:
Add 5 to 10 ml (/ to 1 capful) to a small bath or wash basin of water.
Immerse and cover the affected areas with the bath water and soak for 10 to 20 minutes. Alternatively, repeatedly gently sponge over the affected areas. Pat dry with a towel.
There is no differentiation between the dosage quantities for the symptomatic relief of the conditions listed.
4.3. Contra-Indications
Sensitivity to any of the ingredients.
4.4. Special Warnings and Special Precautions for Use
Take care not to slip in the bath or shower. Surfaces that have been in contact with the product should be cleaned with a proprietary detergent. Keep out of the reach of children. For external use only.
4.5. Interaction with other Medicinal Products and other Forms of Interaction
None known.
4.6. Pregnancy and Lactation
The constituents are not percutaneously absorbed or toxic if ingested. There is no evidence of safety of the drug used in pregnancy or lactation, but the active constituents have been in widespread use and in similar preparations for many years without apparent ill consequence.
4.7. Effects on Ability to Drive and Use Machines
None known.
4.8 Undesirable effects
Contact sensitivity reactions or mild irritant reactions may occur occasionally. In either case, treatment should be discontinued.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal
product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
4.9. Overdose
Accidental ingestion may result in a purgative action due to the liquid paraffin and the oily nature of the product. Treat symptomatically. Fluid and electrolyte replacement may be necessary.
5. PHARMACOLOGICAL PROPERTIES
5.1. Pharmacodynamic Properties
For dry skin conditions it is important to use an emollient while bathing. Dermalo Bath Emollient contains 65% Liquid Paraffin and 5% Acetylated Wool Alcohols for their moisturising and skin softening properties, and is specially formulated to facilitate dispersion in bath water or for ease of application after a shower.
5.2. Pharmacokinetic Properties
The active constituents are not absorbed percutaneously. Pharmacokinetic particulars are thus not relevant.
5.3. Preclinical Safety Data
No relevant information additional to that contained elsewhere in the SPC.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Isopropyl myristate Macrogol isotridecyl ether
6.2.
Incompatibilities
None known.
6.3. Shelf Life
36 months in unopened container.
6.4. Special Precautions for Storage
Do not store above 25oC.
6.5. Nature and Contents of Container
50, 200, 500 or 1000 ml white high density polyethylene BOTTLE fitted with a polyethylene dispensing plug and spigotted polypropylene SCREW CAP.
Supplied in original packs (OP).
6.6. Instruction for Use, Handling and Disposal
Not applicable.
7. MARKETING AUTHORISATION HOLDER
Diomed Developments Limited
T/A Dermal Laboratories
Tatmore Place
Gosmore
Hitchin
Hertfordshire SG4 7QR United Kingdom
8. MARKETING AUTHORISATION NUMBER
PL 00173/0182
9. DATE OF FIRST AUTHORISATION/RENEWAL OF AUTHORISATION
14 February 2000
10
DATE OF REVISION OF THE TEXT
18/09/2015